Activated partial thromboplastin time waveform analysis as specific sepsis marker in cardiopulmonary bypass surgery by Schneider, Christian P et al.
Although our understanding of the pathophysiology of 
sepsis and of subsequently derived therapeutic approaches 
has advanced signiﬁ  cantly in the past, mortality of sepsis 
still remains unacceptably high. To improve this dilemma, 
diagnostic laboratory tests are urgently required that 
possess a high degree of accuracy and for which the 
results can be obtained in a very short time. For patients 
after cardiopulmonary bypass surgery, a recent publica-
tion demonstrated that an activated partial thrombo-
plastin time biphasic waveform (BPW) analysis was able 
to discriminate between sepsis and nonseptic systemic 
inﬂ   ammatory response syndrome (SIRS) with a sensi-
tivity of 100% and a speciﬁ  city of 93% [1]. In all patients, 
pneumonia was the septic focus. Compared with BPW 
analysis, the speciﬁ   city and sensitivity of C-reactive 
protein (CRP) and procalcitonin (PCT) were inferior 
with respect to pneumonia prediction.
Delannoy and colleagues showed that perioperative 
com  pli  cations such as haemorrhage, tamponade or 
reopera  tion were all associated with the emergence of 
postoperative SIRS and sepsis [1]. For cardiac surgical 
patients, these complications are also known to be 
important predictors for prolonged invasive ventilation 
[2]. Th  ose observations are in line with the commonly 
accepted hypothesis that a large tissue trauma or pro-
longed states of shock initially lead to an increased 
inﬂ   ammatory response that is followed by a state of 
immuno  suppression, thereby increas  ing the susceptibility 
to infectious complications [3]. In these patients, however, 
the early and timely diﬀ  erentiation between SIRS and 
sepsis remains diﬃ   cult. If an infectious focus becomes 
clinically evident, it will usually be too late to prevent the 
beginning of the septic vicious circle (for example, by 
initiating speciﬁ  c therapies such as antibiotics or surgical 
interventions) [4].
Postoperative fever is a key symptom requesting an 
urgent search for the underlying cause. Physicians caring 
for patients in intensive care units (ICUs) usually have a 
thorough knowledge of common infectious and non-
infectious mechanisms that may cause fever in their 
patients. Many patients who are actually suﬀ  ering from a 
septic focus, however, do not become febrile at the same 
time (for example, elderly patients or patients with uraemia). 
In those septic patients, the absence of secondary fever or 
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Throughout the last years, several new diagnostic 
biomarkers have been introduced into clinical routine 
to identify a systemic infl  ammatory response syndrome 
(SIRS) or a septic state and to discriminate between 
these two entities. According to studies in selected 
patients, measurement of these biomarkers may be 
advantageous under certain clinical conditions. On an 
individual basis, however, these sepsis markers usually 
lack an adequate negative or positive predictive power. 
Therefore, physicians in charge still have to rely on a 
combination of personal experience and results from 
clinical or laboratory tests when deciding on a patient’s 
therapy. For surgical patients, a key problem consists of 
the time delay which is associated with the diagnosis 
of serious postoperative infections and which may 
negatively aff  ect outcome. It is in this context where 
the activated partial thromboplastin time waveform 
analysis may represent a promising new method 
to discriminate between SIRS and sepsis, thereby 
shortening the time to therapy. Nevertheless, studies 
involving large patient populations will be necessary 
to prove the effi   cacy of this new diagnostic concept 
either as a single tool or in combination with the 
measurement of other biomarkers.
© 2010 BioMed Central Ltd
Activated partial thromboplastin time 
waveform analysis as specifi  c sepsis marker in 
cardiopulmonary bypass surgery
Christian P Schneider*, Martin K Angele and Wolfgang H Hartl
See related research by Delannoy et al., http://ccforum.com/content/13/6/R180
COMMENTARY
*Correspondence: christian.schneider@med.uni-muenchen.de
Department of Surgery, Munich University Hospital, Campus Großhadern, 
Ludwig-Maximilians-University, Marchioninistraße 15, 80933 Munich, Germany
Schneider et al. Critical Care 2010, 14:104 
http://ccforum.com/content/14/1/104
© 2010 BioMed Central Ltdof a general acute-phase response cannot be regarded as 
a favourable prognostic sign, but rather reﬂ  ects  the 
immunosuppressive phase of sepsis being associated with 
a high mortality. Other early manifestations of sepsis 
include a minor increase or decrease in the white-cell 
count or neutrophil percentage, a subtle change of mental 
status, or an elevated blood glucose level.
Early recognition of a septic state and of the septic 
focus is essential for successful treatment. Th  e time to 
diagnosis, however, is often prolonged because key indi-
ca  tors (fever) are either missing, or have low speciﬁ  city 
and sensitivity (leukocyte count), or can be only regis-
tered with a signiﬁ  cant time delay (results from micro-
biological cultures). Because of these weaknesses, the 
availability of new biomarkers (PCT and IL-6) raised high 
hopes for all those caring for septic patients. Th  roughout 
the past years, the accuracy, predictive power and clinical 
utility of those biomarkers has been studied extensively.
A meta-analysis of 33 studies concluded that PCT 
constitutes an excellent laboratory marker for the discri-
mi  nation between SIRS and sepsis [5]. When assessing 
the risk of patients with SIRS to develop sepsis, these 
authors found a global odds ratio of 15.6 when PCT 
concentrations were elevated, whereas the odds ratio was 
only 5.4 with increased CRP levels. Th   e optimal decisional 
cut-oﬀ   point varied between 0.6 and 5 ng/l when PCT 
was analysed, whereas corresponding variations were 
clearly wider for CRP (39 to 180 mg/l). A similar superio-
rity with respect to postoperative risk prediction was also 
found exclusively in surgical patients [6], where the 
accuracy of PCT even surmounted that of IL-6.
In selected patient populations, however, including 
immunosuppressed or very old patients, the diagnostic 
performance of PCT seems to vary [7,8]. In our own 
patient population, we made similar observations. Some 
patients had a normal PCT concentration after solid 
organ transplantation, although there was unequivocal 
evidence for a serious infection. Th  is disease-speciﬁ  c 
PCT reaction may be one of the reasons for the incon-
clusive results from another systematic review published 
recently [9]. Nevertheless, most authors found PCT to be 
superior to CRP or IL-6 [10,11]. It should be noted that 
the use of CRP as a diagnostic tool is not completely 
unhelpful. Studies focusing selectively on CRP attested 
acceptable reliability, with a sensitivity of 85% and a 
speciﬁ   city of about 70%. CRP measurement therefore 
remains an option when PCT testing is not available [12].
Downey and colleagues were the ﬁ   rst to discover an 
abnormality of the optical transmission waveform obtained 
during measurement of the activated partial thrombo-
plastin time (reviewed in [13]). Th   is abnormality, a BPW, is 
caused by in vitro formation of calcium-induced com-
plexes between very-low-density lipo  proteins and CRP. 
Waveform analysis is a rapid and inexpensive method, 
being part of the routine activated partial thromboplastin 
time measurement. BPW analysis was originally intro-
duced as a marker for disseminated intravascular coagula-
tion. Subsequent studies identiﬁ   ed BPW analysis as an 
indicator of a systemic inﬂ  ammatory response, as observed 
in sepsis [13]. Th  e present study by Delannoy and 
colleagues demonstrated that BPW analysis was able to 
discriminate between sepsis and non  septic SIRS patients 
with a sensitivity of 100% and a speciﬁ   city of 93% 
(threshold value of 0.456 %T/second). Only 32 cardiac 
surgery patients, however, were included [1].
An earlier investigation by Chopin and colleagues 
studied 187 patients with 217 episodes of SIRS, of which 
34 patients were classiﬁ  ed with sepsis, 26 patients with 
severe sepsis, and 50 patients with septic shock. Th  e 
diagnostic sensitivity and speciﬁ  city of BPW analysis for 
the combined group of severe sepsis and septic shock were 
92% and 67%, respectively [14]. In another recent study in 
ICU patients, the sensitivity of BPW analysis for sepsis was 
81%, with a speciﬁ  city of 76%. Th  e combination of BPW 
analysis with PCT measurement did not increase the 
sensitivity but raised the speciﬁ  city to 94% [15]. Th   e use of 
BPW analysis, however, is not limited to ICU patients. 
Smith and colleagues found that non-ICU patients are 
more likely to have positive blood cultures when waveform 
analysis yields abnormal results [16].
BPW analysis therefore appears to be a promising 
parameter for the discrimination between SIRS and 
sepsis. To corroborate the use of BPW analysis, however, 
further studies in heterogeneous patient populations 
including larger patient numbers are required. Only if the 
precise diagnostic signiﬁ  cance is established in relation 
to the underlying disease will BPW analysis become an 
important component in the routine panel of sepsis 
markers currently used.
Abbreviations
BPW = biphasic waveform; CRP = C-reactive protein; ICU = intensive care unit; 
IL = interleukin; PCT = procalcitonin; SIRS = systemic infl  ammatory response 
syndrome.
Competing interests
The authors declare that they have no competing interests.
Published: 21 January 2010
References
1.  Delannoy B, Guye ML, Slaiman DH, Lehot JJ, Cannesson M: Eff  ect of 
cardiopulmonary bypass on activated partial thromboplastin time 
waveform analysis, serum procalcitonin and C-reactive protein 
concentrations. Crit Care 2009, 13:R180.
2.  Cislaghi F, Condemi AM, Corona A: Predictors of prolonged mechanical 
ventilation in a cohort of 5123 cardiac surgical patients. Eur J Anaesthesiol 
2009, 26:396-403.
3.  Lenz A, Franklin GA, Cheadle WG: Systemic infl  ammation after trauma. 
Injury 2007, 38:1336-1345.
4.  Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, 
Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey 
M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, 
Townsend S, Vender JS, Zimmerman JL, Vincent JL; International Surviving 
Schneider et al. Critical Care 2010, 14:104 
http://ccforum.com/content/14/1/104
Page 2 of 3Sepsis Campaign Guidelines Committee; American Association of Critical-
Care Nurses; American College of Chest Physicians; American College of 
Emergency Physicians; Canadian Critical Care Society; European Society of 
Clinical Microbiology and Infectious Diseases; European Society of Intensive 
Care Medicine; European Respiratory Society; International Sepsis Forum; 
Japanese Association for Acute Medicine; Japanese Society of Intensive Care 
Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; 
Surgical Infection Society; World Federation of Societies of Intensive and 
Critical Care Medicine: Surviving Sepsis Campaign: international guidelines 
for management of severe sepsis and septic shock: 2008. Crit Care Med 
2008, 36:296-327.
5.  Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a 
diagnostic test for sepsis in critically ill adults and after surgery or trauma: 
a systematic review and meta-analysis. Crit Care Med 2006 34:1996-2003.
6.  Schneider CP, Yilmaz Y, Kleespies A, Jauch KW, Hartl WH: Accuracy of 
procalcitonin for outcome prediction in unselected postoperative 
critically ill patients. Shock 2009, 31:568-673.
7.  Dornbusch HJ, Strenger V, Kerbl R, Lackner H, Schwinger W, Sovinz P, Urban C: 
Procalcitonin and C-reactive protein do not discriminate between febrile 
reaction to anti-T-lymphocyte antibodies and Gram-negative sepsis. Bone 
Marrow Transplant 2003, 32:941-945.
8.  Stucker F, Herrmann F, Graf JD, Michel JP, Krause KH, Gavazzi G: Procalcitonin 
and infection in elderly patients. J Am Geriatr Soc 2005, 53:1392-1395.
9.  Tang BM, Eslick GD, Craig JC, McLean AS: Accuracy of procalcitonin for 
sepsis diagnosis in critically ill patients: systematic review and meta-
analysis. Lancet Infect Dis 2007, 7:210-217.
10.  Brunkhorst FM, Eberhard OK, Brunkhorst R: Discrimination of infectious and 
noninfectious causes of early acute respiratory distress syndrome by 
procalcitonin. Crit Care Med 1999, 27:2172-2176.
11.  Aikawa N, Fujishima S, Endo S, Sekine I, Kogawa K, Yamamoto Y, Kushimoto S, 
Yukioka H, Kato N, Totsuka K, Kikuchi K, Ikeda T, Ikeda K, Harada K, Satomura S: 
Multicenter prospective study of procalcitonin as an indicator of sepsis. 
J Infect Chemother 2005, 11:152-159.
12.  Sierra R, Rello J, Bailén MA, Benítez E, Gordillo A, León C, Pedraza S: C-reactive 
protein used as an early indicator of infection in patients with systemic 
infl  ammatory response syndrome. Intensive Care Med 2004, 30:2038-2045.
13.  Dempfl  e CE, Borggrefe M: The hidden sepsis marker: aPTT waveform 
analysis. Thromb Haemost 2008, 100:9-10.
14.  Chopin N, Floccard B, Sobas F, Illinger J, Boselli E, Benatir F, Levrat A, Guillaume 
C, Crozon J, Négrier C, Allaouchiche B: Activated partial thromboplastin 
time waveform analysis: a new tool to detect infection? Crit Care Med 2006, 
34:1654–1660.
15.  Zakariah AN, Cozzi SM, Van Nuff  elen M, Clausi CM, Pradier O, Vincent JL: 
Combination of biphasic transmittance waveform with blood 
procalcitonin levels for diagnosis of sepsis in acutely ill patients. Crit Care 
Med 2008, 36:1507-1512.
16.  Smith EY, Charles LA, Van Cott EM: Biphasic activated partial thromboplastin 
time waveform and adverse events in non-intensive care unit patients. Am 
J Clin Pathol 2004, 121:138-141.
Schneider et al. Critical Care 2010, 14:104 
http://ccforum.com/content/14/1/104
doi:10.1186/cc8226
Cite this article as: Schneider CP, et al.: Activated partial thromboplastin 
time waveform analysis as specifi  c sepsis marker in cardiopulmonary 
bypass surgery. Critical Care 2010, 14:104.
Page 3 of 3